Home » Stocks » IH

iHuman, Inc. (IH)

Stock Price: $21.51 USD -1.33 (-5.82%)
Updated Jan 25, 2021 4:00 PM EST - Market closed
Pre-market: $21.56 +0.05 (0.23%) Jan 26, 7:37 AM
Market Cap 1.15B
Revenue (ttm) 44.24M
Net Income (ttm) 263,031
Shares Out 52.27M
EPS (ttm) 0.01
PE Ratio 4,274.87
Forward PE 270.27
Dividend n/a
Dividend Yield n/a
Trading Day January 25
Last Price $21.51
Previous Close $22.84
Change ($) -1.33
Change (%) -5.82%
Day's Open 22.91
Day's Range 21.10 - 24.50
Day's Volume 188,053
52-Week Range 16.00 - 29.86


Hide News
PRNewsWire - 1 month ago

BEIJING, Dec. 2, 2020 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading childhood edutainment company in China, today announced its unaudited financial results for ...

PR Newswire - 3 months ago

iHuman Inc. (NYSE: IH), a leading childhood edutainment company in China, announced today the pricing of its initial public offering of 7,000,000 American Depositary Shares, each representing ...

Seeking Alpha - 3 months ago

iHuman has filed to raise investment capital in a U.S. IPO.

About IH

iHuman provides childhood edutainment products and services to individual users, education organizations, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman English World, iHuman Pinyin, iHuman Magic Math, iHuman Books, and iHuman Stories. It also provides learning materials in physical and digital formats; and smart learning devices. The company was founded in 1996 and is based in Beijing, the People's Republic of China.

Education & Training Services
IPO Date
Oct 9, 2020
Peng Dai
Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

In 2019, iHuman's revenue was 218.66 million, an increase of 65.82% compared to the previous year's 131.87 million. Losses were -275.60 million, 1,465.5% more than in 2018.

Financial numbers in millions CNY.
Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for iHuman stock is "Strong Buy." The 12-month stock price forecast is 4.04, which is a decrease of -81.22% from the latest price.

Price Target
(-81.22% downside)
Analyst Consensus: Strong Buy